BioLineRx (BLRX) Other Non Operating Income (2014)
BioLineRx (BLRX) posted quarterly Other Non Operating Income of -$1.1 million for Q4 2014, up 45.98% quarter-over-quarter from -$2.0 million in Q3 2014.
BioLineRx (BLRX) Other Non Operating Income (2014) Analysis & Trends
BioLineRx's Other Non Operating Income history runs 1 years deep, the most recent figure standing at -$1.1 million for Q4 2014.
- In Q4 2014, Other Non Operating Income changed N/A year-over-year to -$1.1 million; the TTM figure through Dec 2014 stood at -$2.8 million (changed N/A YoY), while the FY2014 annual figure was -$2.8 million, down 358.34% from the prior year.
- Other Non Operating Income for Q4 2014 stood at -$1.1 million, up from -$2.0 million in the prior quarter.
- The five-year high for Other Non Operating Income was $424000.0 in Q2 2014, with the low at -$2.0 million in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BioLineRx | 7.21 Bn | 7.21 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -1.10 Mn |
| Sep 30, 2014 | -2.03 Mn |
| Jun 30, 2014 | 424,000.00 |
| Mar 31, 2014 | -136,000.00 |